Soligenix Stock Alpha and Beta Analysis

SNGX Stock  USD 3.33  0.01  0.30%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Soligenix. It also helps investors analyze the systematic and unsystematic risks associated with investing in Soligenix over a specified time horizon. Remember, high Soligenix's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Soligenix's market risk premium analysis include:
Beta
(0.40)
Alpha
(0.02)
Risk
5.91
Sharpe Ratio
0.015
Expected Return
0.0884
Please note that although Soligenix alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Soligenix did 0.02  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Soligenix stock's relative risk over its benchmark. Soligenix has a beta of 0.40  . As returns on the market increase, returns on owning Soligenix are expected to decrease at a much lower rate. During the bear market, Soligenix is likely to outperform the market. At this time, Soligenix's Price Book Value Ratio is fairly stable compared to the past year. Price Fair Value is likely to rise to 2.45 in 2024, whereas Book Value Per Share is likely to drop 4.94 in 2024.

Enterprise Value

878,857

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Soligenix Backtesting, Soligenix Valuation, Soligenix Correlation, Soligenix Hype Analysis, Soligenix Volatility, Soligenix History and analyze Soligenix Performance.
For more information on how to buy Soligenix Stock please use our How to Invest in Soligenix guide.

Soligenix Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Soligenix market risk premium is the additional return an investor will receive from holding Soligenix long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Soligenix. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Soligenix's performance over market.
α-0.02   β-0.4

Soligenix expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Soligenix's Buy-and-hold return. Our buy-and-hold chart shows how Soligenix performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Soligenix Market Price Analysis

Market price analysis indicators help investors to evaluate how Soligenix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Soligenix shares will generate the highest return on investment. By understating and applying Soligenix stock market price indicators, traders can identify Soligenix position entry and exit signals to maximize returns.

Soligenix Return and Market Media

The median price of Soligenix for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 3.68 with a coefficient of variation of 7.16. The daily time series for the period is distributed with a sample standard deviation of 0.27, arithmetic mean of 3.71, and mean deviation of 0.2. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Acquisition by Cote Timothy R. of 15000 shares of Soligenix at 1.42 subject to Rule 16b-3
09/16/2024
2
Soligenix Announces Partnership with Sterling Pharma Solutions
10/03/2024
3
Acquisition by Zeldis Jerome B of 38136 shares of Soligenix at 0.59 subject to Rule 16b-3
10/18/2024
4
Soligenix, Inc. to Present at the 2024 ThinkEquity Conference
10/24/2024
5
Soligenix Initiates a Phase 2 Clinical Trial of SGX945 for the treatment of Behets Disease
11/14/2024
6
Soligenix, A Pharmaceutical Firm Tackling Potentially Lucrative Unmet Medical Needs
11/26/2024

About Soligenix Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Soligenix or other stocks. Alpha measures the amount that position in Soligenix has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 (projected)
Dividend Yield0.0029590.002811
Price To Sales Ratio7.06.65

Soligenix Upcoming Company Events

As portrayed in its financial statements, the presentation of Soligenix's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Soligenix's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Soligenix's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Soligenix. Please utilize our Beneish M Score to check the likelihood of Soligenix's management manipulating its earnings.
29th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Soligenix

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Soligenix Stock Analysis

When running Soligenix's price analysis, check to measure Soligenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Soligenix is operating at the current time. Most of Soligenix's value examination focuses on studying past and present price action to predict the probability of Soligenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Soligenix's price. Additionally, you may evaluate how the addition of Soligenix to your portfolios can decrease your overall portfolio volatility.